Asymptomatic or minimally symptomatic hyperCKemia: Histopathologic correlates

Israel Medical Association Journal

Volumn 8, Issue 2, 2006, Pages 110-113

  Dabby, Ron ^a   Sadeh, Menachem ^a   Herman, Oscar ^a   Berger, Esther ^a   Watemberg, Nathan ^a   Hayek, Shlomo ^b,c   Jossiphov, Joseph ^b,c   Nevo, Yoram ^b,c  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dystrophinopathy; Electromyography; HyperCKemia; Muscle biopsy; Myopathy

Indexed keywords

CAVEOLIN 3; CREATINE KINASE; DYSFERLIN; DYSTROPHIN; GLYCOGEN; MEROSIN; SARCOGLYCAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL COUNT; CELL NUCLEUS; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; ELECTROMYOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIPID STORAGE; MALE; METABOLIC DISORDER; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NEUROLOGIC EXAMINATION; SCHOOL CHILD; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; CREATINE KINASE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NEUROMUSCULAR DISEASES; RISK ASSESSMENT; RISK FACTORS;

EID: 33244496467     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Munsat TL, Baloh R, Pearson CM, Fowler W Jr. Serum enzyme alteration in neuromuscular disorders. JAMA 1973;226:1536-43.
2. Imai Y, Watanabe N, Hashimoto J, et al. Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoreceptor blockers. Eur J Clin Pharmacol 1995;48:29-34.
3. London SF, Gross KF, Ringel SP Cholesterol-lowering agent myopathy (CLAM). Neurology 1991;41:1159-60.
4. Scelsa SN, Simpson DM, McQuistion HL, Fineman A, Ault K, Reichler B. Clozapine-induced myotoxicity in patients with chronic psychotic disorders, Neurology 1996;47:1518-23.
5. Bär PR, Reijneveld JC, Wokke JHJ, Jacobs SCJM, Bootsma AL. Muscle damage induced by exercise: nature, prevention and repair. In: Salmons S, ed. Muscle Damage. Oxford: Oxford University Press, 1997:1-27.
6. Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patientswith persistently increased serum creatine kinase levels. Anesth Analg 1997;84:1038-41.
7. Doran K, Wilkinson JH. The origin of elevated activities of creatine kinase and other enzymes in the sera of patients with myxoedema. Clin Chim Acta 1975;62:203-11.
8. Hagberg M, Michaelson G, Ortelius A. Serum creatine kinase as an indicator of local muscular strain in experimental and occupational work. Int Arch Occup Environ Health 1982;50:377-86.
9. Nicholson GA, Morgan JG, Meerkin M, Strauss ER, McLeod JG. The effect of aerobic exercise on serum creatine kinase activities. Muscle Nerve 1986;9:820-4.
10. Olivier LR, De Waal A, Retief FJ, et al, Electrocardiographic and biochemical studies on marathon runners. S Afr Med J 1978;53:783-7.
11. Rowland LP, Willner J, Cerri C, DiMauro S, Miranda A. Approaches to the membrane theory of Duchenne muscular dystrophy. In: Angelini C, Danielli GA, Fontanari D, eds. Muscular Dystrophy Research: Advances and New Trends. Amsterdam: Excerpta Medica, 1980:3-13.
12. Reijneveld JC, Notermans NC, Linssen WHJP, Wokke JHJ. Benign prognosis in idiopathic hyper-ck-emia. Muscle Nerve 2000;23:575-9.
13. Joy JL, Oh SJ. Asymptomatic hyper-CK-emia: an electrophysiologic and histopathologic study. Muscle Nerve 1989;12:206-9.
14. Brewster LM, de Visser M. Persistent hyperCKemia: fourteen patients studied in retrospect. Acta Neurol Scand 1988;77:60-3.
15. Fischer D, Schroers A, Blümcke I, et al. Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol 2003;53:233-41.
16. Merlini L, Carbone I, Capanni C, et al, Familial isolated hyperCKemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 2002;73:65-7.
17. Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000;28:1373-6.
18. Doriguzzi C, Palmucci L, Mongini T, et al, Variable histological expression of dystrophinopathy in two females. Acta Neuropathol (Berl) 1999;97:657-60.
19. Prelle A, Tancredi L, Sciacco M, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002;249:305-11.
20. Comi GP. Prelle A, Bresolin N, et al. Clinical variability in the Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates. Brain 1994; 117:1-14.
21. Serratrice G, Pellissier JF, N'guyen V, Attarian S, Pouget J. Dysferlinopathy. Example of a new myopathy. Bull Acad Natl Med 2002; 186:1025-32.
22. Chiba Y, Shinde A, Kohara N, et al. Two sisters with dysferlinopathy manifesting different clinic phenotype. Rinsho Shinkeigaku 2003;43:188-91.
23. Fanin M, Angelini C. Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol 2002;28:461-70.
24. Ginjaar HB, van der Kooi AJ, Ceelie H, et al. Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy. J Neurol 2000;247:524-9.
25. Cagliani R, Comi GP, Tancredi L, et al. Primary beta-sarcogly-canopathy manifesting as recurrent exercise-induced myoglobinuria. Neuromuscul Disord 2001;11:38 9-94.